| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |